Health Strategies realigns its service

Share this article:

Health Strategies Group, a provider of market intelligence to the pharmaceutical and biotechnology industries, has realigned its pharmaceutical sales force effectiveness service under a more strategic, future-oriented business vision and renamed the group Strategic Selling Outlook. 


The goal of these changes is to help clients address the complex issues posed by today's selling environment and to anticipate and navigate the selling environments of the future. According to Rick Rosenthal, a principal at Health Strategies Group and leader of the company's sales force effectiveness practice, said: "The world is changing dramatically for those involved in pharmaceutical sales and the wisest course of action is to embrace that change and make use of the opportunities it presents." He added that information that is immediately actionable against a specific challenge is good, but today's selling environment requires information that helps pharmas assess physician attitudes and prescribing behavior over time.


He said that strategically, it's critical to get ahead of emerging trends and uncover unmet needs and gaps in knowledge. "Our goal with Strategic Selling Outlook is to provide both types of intelligence."


Rosenthal asserted: "We have to understand what doctors value and want in sales representatives today along with what they'll value and want tomorrow." 


Rosenthal pointed out that the physician's world has changed significantly in the past decade and will continue to change. In order to be effective, he said, sales representatives must keep pace with this change and expand the scope of services they provide. 


According to Health Strategies Group, Strategic Selling Outlook gives pharma companies a complete picture of the selling environment for the upcoming year as well as scenarios five years down the road. 


Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"